Company Filing History:
9 out of 1,343 
1 out of 49 Years Active: 2021-2025
Title: Katherine Cygnar: Pioneering Innovations in Antigen-Binding Molecules
Introduction
Katherine Cygnar, a prominent inventor based in New York, NY, has made significant strides in the field of biomedical research. With an impressive portfolio of 10 patents, she has contributed to the advancement of innovative technologies aimed at improving therapeutic outcomes.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Multispecific antigen-binding molecules and uses thereof". This invention introduces multispecific antigen-binding molecules that consist of a first antigen-binding domain, specifically designed to bind to a target molecule, along with a second domain that binds to an internalizing effector protein. The unique configuration allows for enhanced efficacy in targeted therapies, particularly in the context of tumor-associated antigens, where the simultaneous binding can facilitate the targeted killing of cancer cells.
Another notable patent is focused on "Methods and compositions for therapeutic protein delivery". This invention outlines compositions and methodologies for delivering therapeutic proteins to the central nervous system (CNS), addressing diseases that hinder CNS function. The approach involves a combination of nucleotide compositions encoding therapeutic proteins, paired with receptor-binding proteins that can penetrate the blood-brain barrier, offering new hope for treating lysosomal storage diseases.
Career Highlights
Katherine has garnered experience through her work with notable companies such as Regeneron Pharmaceuticals, Inc., where she has been influential in developing innovative therapeutic solutions. Her expertise in the field has positioned her as a key figure in advancing medical research and patent development.
Collaborations
Throughout her career, Katherine has collaborated with accomplished professionals like Andrew Baik and Nicholas J Papadopoulos. These partnerships have enriched her research endeavors and propelled the development of her innovative inventions.
Conclusion
In conclusion, Katherine Cygnar stands out as a remarkable inventor, whose contributions to the field of antigen-binding molecules and therapeutic protein delivery are paving the way for advancements in medical treatments. Her dedication to innovation continues to inspire future developments in the biomedical sector.